New York Times
Hospitals that buy surgical robots end up performing more prostate cancer operations, suggesting that technology has become a driving force behind decisions about men’s cancer care, new research shows.
The study, published in the journal Medical Care,
is the latest report to suggest that how men are treated for prostate
cancer appears to be influenced by a variety of factors, including the
technology and marketing goals of hospitals and doctors, rather than
scientific evidence on benefits and risks... Read More